5 IVD Companies to Watch Out for in the US

There are few industries that have enjoyed growth like the IVD market in the last 20 years. It’s now worth $69bn annually.

The North American market makes up almost half of this ($31bn) and the US remains the largest single-country market in the world.

While the growth rate is expected to slow in the states, there are certain areas investors are getting excited about. These include next-generation sequencing (NGS), cancer testing and companion diagnostic technologies.

Working exclusively in the IVD talent market, I’m constantly coming across new companies in these areas – both big and small.

Please read my full article the five that I think you need to keep an eye on this year in the US.